AVL-292 is a potent and specific Brutons tyrosine kinase (Btk) inhibitor. Studies showed that AVL-292 used in combination with Carfilzomib (C183460) impacted the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity. Molecular Formula: C22H22FN5O3 Molecular Weight: 423.44 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
423.44
CAS Nummer:
[1202757-89-8]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten